Home Online Features Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
Hand-out
Press Releases
Novavax, Inc.  
December 10, 2024

Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza

Company continuing to work with the U.S. FDA on potential for accelerated approval pathwayNovavax intends to partner on both candidates to advance to filing and commercialization

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social